First-Line Treatment of Calciphylaxis
Calciphylaxis demands prompt, coordinated first-line intervention. Management is multipronged — addressing the underlying disease process, risk factors, wound burden, and pain simultaneously. The clinical target is healing of cutaneous calciphylaxis lesions, guided by close monitoring of active wounds.
Treatment Approach
First-line management centers on intravenous sodium thiosulfate alongside targeted withdrawal of risk-inducing medications, wound care with appropriate debridement, and multimodal analgesia — the full regimen, agent selection, and decision criteria are detailed in the structured protocol.
Clinical Goal
Healing of cutaneous calciphylaxis lesions, tracked through close clinical monitoring of active lesions.
References
DOI: 10.1053/j.ajkd.2022.06.011
- Arguably equally important as active treatment is the elimination of risk factors for calciphylaxis, which would potentially include withdrawal of warfarin (vitamin K antagonist), vitamin D, and calcium-based phosphate binders.
- Reported wound-care modalities include enzymatic debridement, atraumatic debridement with sterile maggots, and judicious surgical debridement.
- The severe pain associated with calciphylaxis often requires multimodal analgesia.